Scientists identified patients with acute myeloid leukemia who underwent hematopoietic stem cell transplantation and had existing baseline plasma samples. Using those samples, they studied 65 blood based metabolomic and 61 immune/inflammatory related biomarkers, comparing patients with either long-term overall survival (OS) or short-term OS.
[PLoS One]